About William Cortelyou
William Cortelyou is chairman of the board of Araceli Biosciences, a company that builds imaging hardware and AI analysis software for drug discovery labs.
He was the lead investor in Araceli's $11.2 million seed financing, completed in April 2025, which combined new equity with converted SAFE notes.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name William Cortelyou in the role, so the role may have started earlier or lasted longer.
Araceli Biosciences Inc. Current
Chairman of the Board
2023 – Present · Tigard, OR
Araceli Biosciences makes high-content imaging and AI analysis systems that help drug discovery labs screen compounds faster.
Key Colleagues at Startups
The people William Cortelyou works with at each company, as listed on that company's latest Form D.
Araceli Biosciences Inc. · Form D, Nov 3, 2026
Matt Beaudet
President and CEO, director
J. William Freytag
Director
Kirk Malloy
Director
Sean O'Neill
Director
SR
Samraat Raha
Director
Bruce Rhine
Director
Christine Ann Tsingos
Director